Loading...
Loading...
HTGM| Name | Value |
|---|---|
| Revenues | 1,032.5K |
| Cost of Revenue | 1,149.6K |
| Gross Profit | -117.1K |
| Operating Expense | 4,895.5K |
| Operating I/L | -5,012.6K |
| Other Income/Expense | -40.0K |
| Interest Income | 98.4K |
| Pretax | -5,052.6K |
| Income Tax Expense | 2.2K |
| Net Income/Loss | -5,054.8K |
HTG Molecular Diagnostics, Inc. is a life sciences company specializing in precision medicine. The company offers instruments, consumables, and software for automating sample processing and molecular target profiling. Its molecular profiling panels include HTG Transcriptome Panel, HTG EdgeSeq precision immuno-oncology panel, and HTG EdgeSeq miRNA whole-transcriptome assay. HTG distributes its products directly in the United States and Europe, and through international distributors. Its customers include biopharmaceutical companies, academic research centers, and molecular testing laboratories. The company generates revenue through the sale of instruments, consumables, and software to its diverse customer base.
